Jonas Saal

[JNCI @JNCI_Now]

Longitudinal CRP kinetics predicts immunotherapy response in NSCLC! First validation of CRP kinetics in Phase III clinical trial. Great cost-efficient and easy-to-implement tool for therapy monitoring @niklas_kluemper @saal_jonas @IEO_Bonn @UniBonn
Read: https://t.co/GtYKMWhQom

[Niklas Klümper @niklas_kluemper]

Happy to share our work: Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma @JAMAOnc. See our tweetorial and the terrific editorial by @ggebraelmd @GliceidaGalarza @neerajaiims @urotoday 1/7